Navivumab
Product Specifications
CAS Number
1443004-16-7
Target
Influenza Virus
Related Pathways
Microbiology/Virology
Bioactivity
Navivumab (CT-P23) is a monoclonal antibody targeting the hemagglutinin HA of the influenza A virus, effectively neutralizing strains H1, H2, H5, and H9 by binding to the HA2 stem fusion domain [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1034213-01 0.05 mg (E-Coli)
Recombinant Mesocricetus auratus Neutrophil defensin 4
Sign In for Pricing
View Details MBS1034213-02 0.2 mg (E-Coli)
Recombinant Mesocricetus auratus Neutrophil defensin 4
Sign In for Pricing
View Details 
MBS1034213-03 0.05 mg (Yeast)
Recombinant Mesocricetus auratus Neutrophil defensin 4
Sign In for Pricing
View Details MBS1034213-04 0.5 mg (E-Coli)
Recombinant Mesocricetus auratus Neutrophil defensin 4
Sign In for Pricing
View Details MBS1034213-05 0.05 mg (Baculovirus)
Recombinant Mesocricetus auratus Neutrophil defensin 4
Sign In for Pricing
View Details